In Vivo Activation of Naive CD4+ T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with Recombinant Streptococcus gordonii

ABSTRACT The antigen-specific primary activation of CD4+ T cells was studied in vivo by adoptive transfer of ovalbumin-specific transgenic T cells (KJ1-26+ CD4+) following intranasal immunization with recombinant Streptococcus gordonii. A strain of S. gordonii expressing on its surface a model vaccine antigen fused to the ovalbumin (OVA) peptide from position 323 to 339 was constructed and used to study the OVA-specific T-cell activation in nasal mucosa-associated lymphoid tissue (NALT), lymph nodes, and spleens of mice immunized by the intranasal route. The recombinant strain, but not the wild type, activated the OVA-specific CD4+ T-cell population in the NALT (89% of KJ1-26+ CD4+ T cells) just 3 days following immunization. In the cervical lymph nodes and in the spleen, the percentage of proliferating cells was initially low, but it reached the peak of activation at day 5 (90%). This antigen-specific clonal expansion of KJ1-26+ CD4+ T cells after intranasal immunization was obtained with live and inactivated recombinant bacteria, and it indicates that the NALT is the site of antigen-specific T-cell priming.

[1]  J. Mcghee,et al.  Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. , 1999, The Journal of infectious diseases.

[2]  J. Bienenstock,et al.  Bronchus‐ and nasal‐associated lymphoid tissues , 2005, Immunological reviews.

[3]  J. Samsom,et al.  Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells. , 2003, International immunology.

[4]  M. Jenkins,et al.  Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection. , 2002, Immunity.

[5]  K. Francis,et al.  Membranous Cells in Nasal-Associated Lymphoid Tissue: A Portal of Entry for the Respiratory Mucosal Pathogen Group A Streptococcus 1 , 2003, The Journal of Immunology.

[6]  V. Fischetti,et al.  Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Russell,et al.  Nasal Lymphoid Tissue (NALT) as a Mucosal Immune Inductive Site , 1997, Scandinavian journal of immunology.

[8]  Kevin F. Jones,et al.  Clinical and Microbiological Responses of Volunteers to Combined Intranasal and Oral Inoculation with a Streptococcus gordonii Carrier Strain Intended for Future Use as a Group A Streptococcus Vaccine , 2005, Infection and Immunity.

[9]  M. Jenkins,et al.  Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection , 2004, European journal of immunology.

[10]  A. Zuercher.  Upper respiratory tract immunity. , 2003, Viral immunology.

[11]  P. Marrack,et al.  The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody , 1983, The Journal of experimental medicine.

[12]  A. B. Lyons,et al.  Determination of lymphocyte division by flow cytometry. , 1994, Journal of immunological methods.

[13]  P. Ricciardi-Castagnoli,et al.  Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Buer,et al.  Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues , 2005, The Journal of Immunology.

[15]  G. Girolomoni,et al.  Human Dendritic Cells Are Superior to B Cells at Presenting a Major Histocompatibility Complex Class II-Restricted Heterologous Antigen Expressed on Recombinant Streptococcus gordonii , 2000, Infection and Immunity.

[16]  C. Kuper,et al.  Nasal lymphoid tissue in the rat , 2004, Cell and Tissue Research.

[17]  A. Heimberger,et al.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.

[18]  G. Pozzi,et al.  Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface. , 2002, FEMS microbiology letters.

[19]  V. Fischetti,et al.  Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. , 1994, Vaccine.

[20]  M. Russell,et al.  Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissue , 1996, Immunology.

[21]  G. Pozzi,et al.  Vaginal Immunization with Recombinant Gram‐Positive Bacteria , 1998, American journal of reproductive immunology.

[22]  A. Zuercher,et al.  Nasal-Associated Lymphoid Tissue Is a Mucosal Inductive Site for Virus-Specific Humoral and Cellular Immune Responses1 , 2002, The Journal of Immunology.

[23]  M. Russell,et al.  Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit , 1993, Infection and immunity.

[24]  G. Pozzi,et al.  A host-vector system for heterologous gene expression in Streptococcus gordonii. , 1996, Gene.

[25]  S. Husby,et al.  Suppression of the immune response by nasal immunization. , 1994, Clinical immunology and immunopathology.

[26]  J. Mcghee,et al.  Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. , 1998, Journal of immunology.

[27]  P. Plevani,et al.  Method and parameters for genetic transformation of Streptococcus sanguis Challis. , 1990, Research in microbiology.

[28]  M. Russell,et al.  Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system , 1997, Immunologic research.

[29]  T. Iwasaki,et al.  Isolation and characterization of mouse nasal-associated lymphoid tissue. , 1997, Journal of immunological methods.

[30]  G. Pozzi,et al.  Recombinant Gram-positive bacteria as vehicles of vaccine antigens , 1997 .

[31]  Toru Nakamura,et al.  Isotype-specific Selection of High Affinity Memory B Cells in Nasal-associated Lymphoid Tissue , 2001, The Journal of experimental medicine.

[32]  A. Arsenault,et al.  Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. , 1997, American journal of respiratory and critical care medicine.

[33]  A. Porgador,et al.  Intranasal Immunization with Cytotoxic T-Lymphocyte Epitope Peptide and Mucosal Adjuvant Cholera Toxin: Selective Augmentation of Peptide-Presenting Dendritic Cells in Nasal Mucosa-Associated Lymphoid Tissue , 1998, Infection and Immunity.

[34]  G. Pozzi,et al.  Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens. , 1998, Vaccine.

[35]  A. Khoruts,et al.  Use of adoptive transfer of T‐cell antigen‐receptor‐transgenic T cells for the study of T‐cell activation in vivo , 1997, Immunological reviews.

[36]  C. Muller,et al.  Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus. , 1995, The Journal of general virology.

[37]  A. B. Lyons,et al.  Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.

[38]  H. Shimauchi,et al.  Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. , 1999, Journal of immunology.

[39]  J. Holmgren,et al.  Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina , 1997, Infection and immunity.

[40]  J. Biewenga,et al.  The role of nasopharyngeal lymphoid tissue. , 1992, Immunology today.

[41]  S. Fukuyama,et al.  NALT- versus PEYER'S-patch-mediated mucosal immunity , 2004, Nature Reviews Immunology.

[42]  M. Zazzi,et al.  Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii. , 1999, AIDS research and human retroviruses.

[43]  G. Pozzi,et al.  Engineering the gram-positive cell surface for construction of bacterial vaccine vectors. , 1999, Methods.

[44]  G. Dougan,et al.  Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant , 1996, Infection and immunity.

[45]  H. Kiyono,et al.  Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal‐associated lymphoid tissues and nasal passage, respectively , 1998, European journal of immunology.

[46]  P. Marrack,et al.  The major histocompatibility complex-restricted antigen receptor on T cells. , 1984, Annual review of immunology.

[47]  G. Palù,et al.  Immunogenicity of the B Monomer ofEscherichia coli Heat-Labile Toxin Expressed on the Surface of Streptococcus gordonii , 2000, Infection and Immunity.

[48]  J. Eldridge,et al.  Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres , 1995, Infection and immunity.

[49]  T. Nagamine,et al.  Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. , 1990, Vaccine.

[50]  P. Ricciardi-Castagnoli,et al.  Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes. , 1999, Journal of immunology.

[51]  P. Sestini,et al.  Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice. , 1997, Vaccine.

[52]  S. Langermann,et al.  Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi , 1994, Nature.

[53]  M. Tommasino,et al.  Immunization of mice by oral colonization with live recombinant commensal streptococci. , 1995, Vaccine.

[54]  A. Ciabattini,et al.  Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice. , 2001, Vaccine.

[55]  H. Grey,et al.  Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen. , 1984, Journal of immunology.